As BRAF inhibitor treatment also significantly enhanced BIM expression in BRAFV600E CRC cells (Fig. 1, Supplementary Fig. 2), we next assessed whether BIM was required for BRAF + BCL-XL inhibitor-induced apoptosis. This evidence concerns the gene BCL2L11 and colorectal carcinoma.